This content is from: Premium

The New Hedge Fund That Surged 200 Percent in 2020

Suvretta Capital affiliate Averill posted eye-popping returns, while Suvretta posted very strong gains of its own.

Averill, the new biopharmaceutical fund managed by a team under the Suvretta Capital umbrella, posted blowout returns for its first partial year of trading, according to a communication sent to clients and seen by Institutional Investor.Averill, which manages about $350 million and began trading on March 23, gains between 195

To continue reading, subscribe now to Premium Journalism. Already a subscriber? Login.

Related Content